Nội dung được dịch bởi AI, chỉ mang tính chất tham khảo
Tình trạng kiểm soát huyết áp không tối ưu ở nhóm người trẻ huyết áp cao
Tóm tắt
Tỷ lệ tăng huyết áp (THA) ở những người trẻ tuổi từ 18 đến 39 tuổi trên toàn cầu ước tính là từ 3,7% đến 8,6%. Mặc dù tỷ lệ THA ở người trẻ tuổi thấp hơn so với dân số chung, nhưng những người mắc THA có nguy cơ đáng kể cao hơn về các sự kiện tim mạch so với những người không mắc THA. THA ở người trẻ tuổi cần được chú ý hơn nữa, vì thời gian tiếp xúc với huyết áp cao kéo dài dẫn đến nguy cơ cao hơn về tổn thương cơ quan do THA trong suốt cuộc đời. Tuy nhiên, những bệnh nhân trẻ mắc THA lại cho thấy nhận thức thấp về THA so với những bệnh nhân lớn tuổi. Họ cũng có xu hướng tuân thủ điều trị kém mặc dù phương pháp điều trị cho thấy hiệu quả tốt. Các yếu tố rủi ro khác cản trở việc kiểm soát THA ở người trẻ tuổi bao gồm việc tiêu thụ rượu, hút thuốc, ít hoạt động thể chất, căng thẳng tâm lý, căng thẳng công việc, hội chứng chuyển hóa và béo phì. Bài tổng quan này nhằm minh họa tình trạng kiểm soát không tối ưu của nhóm người trẻ huyết áp cao và đề xuất các chiến lược cải thiện.
Từ khóa
#tăng huyết áp #người trẻ tuổi #sự kiện tim mạch #nhận thức #tuân thủ điều trị #yếu tố nguy cơTài liệu tham khảo
Pyun WB. Hypertension Control in Young Population: the Earlier, the Better. Korean Circ J. 2020;50(12):1092–4.
Lee HY, et al. Suboptimal Management Status of Younger Hypertensive Population in Korea. Korean Circ J. 2021;51(7):598–606.
Kim HC, et al. Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women. Clin Hypertens. 2022;28(1):1.
Williams B, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.
Kim HC, et al. 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension. Clin Hypertens. 2019;25:16.
Kim KI, et al. 2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations. Clin Hypertens. 2019;25:19.
Lee HY, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25:20.
Unger T, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57.
Hinton TC, et al. Investigation and Treatment of High Blood Pressure in Young People: Too Much Medicine or Appropriate Risk Reduction? Hypertension. 2020;75(1):16–22.
Kim HL, et al. The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension. Clin Hypertens. 2023;29(1):11.
Lebeau JP, et al. The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review. BMC Fam Pract. 2014;15:130.
Moser M. Physician or clinical inertia: what is it? Is it really a problem? And what can be done about it? J Clin Hypertens (Greenwich). 2009;11(1):1–4.
Lee HY, Lee KS. Withdrawal of antihypertensive medication in young to middle-aged adults: a prospective, single-group, intervention study. Clin Hypertens. 2023;29(1):1.
Collaboration, N.C.D.R.F., Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021. 398(10304): 957–980.
Hisamatsu T, et al. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines. Hypertens Res. 2020;43(12):1344–51.
Kim HC, et al. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens. 2021;27(1):8.
Zhang Y, Moran AE. Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014. Hypertension. 2017;70(4):736–42.
Fryar CD, O.Y., Hales CM, Zhang G, Kruszon-Moran D, Hypertension prevalence and control among adults: United States, 2015–2016. NCHS Data Brief, 2017. 289: p. 1–8.
Satoh A, et al. Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010. J Hypertens. 2017;35(2):401–8.
Otani K, Haruyama R, Gilmour S. Prevalence and Correlates of Hypertension among Japanese Adults, 1975 to 2010. Int J Environ Res Public Health. 2018;15(8):1645.
Wang Z, et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015. Circulation. 2018;137(22):2344–56.
Stergiou GS, et al. Prevalence, awareness, treatment and control of hypertension in Greece: EMENO national epidemiological study. J Hypertens. 2021;39(5):1034–9.
Sanuade OA, Boatemaa S, Kushitor MK. Hypertension prevalence, awareness, treatment and control in Ghanaian population: Evidence from the Ghana demographic and health survey. PLoS One. 2018;13(11).
Stergiou GS, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–302.
Carnethon MR, et al. Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA. 2003;290(23):3092–100.
Juonala M, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365(20):1876–85.
Sahoo K, et al. Childhood obesity: causes and consequences. J Family Med Prim Care. 2015;4(2):187–92.
Lee SE, et al. Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009–2013). PLoS One. 2018;13(3):e0194490.
Kwon CH, et al. Optimal office blood pressure levels in younger (<50 years old) Korean hypertensive patients: a nationwide cohort study in South Korea. J Hypertens. 2022;40(12):2449–58.
Son JS, et al. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events. JAMA. 2018;320(17):1783–92.
Suvila, K., et al., Early onset hypertension is associated with hypertensive end-organ damage already by MidLife. Hypertension, 2019: p. HYPERTENSIONAHA11913069.
Yaffe K, et al. Early adult to midlife cardiovascular risk factors and cognitive function. Circulation. 2014;129(15):1560–7.
Franklin SS, et al. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study Circulation. 1999;100(4):354–60.
Scott H, Barton MJ, Johnston ANB. Isolated systolic hypertension in young males: a scoping review. Clin Hypertens. 2021;27(1):12.
Palatini, P., et al., Factors affecting ambulatory blood pressure reproducibility. Results of the HARVEST Trial. Hypertension and ambulatory recording Venetia Study. Hypertension 1994. 23(2):211–6.
Kjeldsen S, et al. Updated national and international hypertension guidelines: a review of current recommendations. Drugs. 2014;74(17):2033–51.
Williamson W, et al. Will Exercise Advice Be Sufficient for Treatment of Young Adults With Prehypertension and Hypertension? A Systematic Review and Meta-Analysis. Hypertension. 2016;68(1):78–87.
Cho JH, Ko J, Lim ST. Relationship between metabolic syndrome and moderate-to-vigorous physical activity among adults 18 years old and over. PLoS One. 2021;16(10).
Goto R, et al. Evaluation of Obesity Trends Among US Adolescents by Socioeconomic Status, 1999–2018. JAMA Pediatr. 2022;176(9):937–40.
Lee HY, et al. May Measurement Month 2019: an analysis of blood pressure screening results from Korea. Eur Heart J Suppl. 2021;23(Suppl B):B89–91.
Stergiou GS, et al. Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on blood pressure monitoring and vardiovascular variability. J Hypertens. 2022;40(8):1449–60.
Lee HY, et al. Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of Hypertension. Clin Hypertens. 2021;27(1):4.
Mukkamala R, et al. Evaluation of the accuracy of cuffless blood pressure measurement devices: challenges and proposals. Hypertension. 2021;78(5):1161–7.
Kim JS, Kim CG. Gender differences in hypertension treatment and control in young adults. J Nurs Res. 2020;28(3).
Johnson, H.M., et al., I have to live like I'm old. Young adults' perspectives on managing hypertension: a multi-center qualitative study. BMC Fam Pract, 2016. 17: p. 31.
Karnilowicz W. Identity and psychological ownership in chronic illness and disease state. Eur J Cancer Care (Engl). 2011;20(2):276–82.
Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol. 2009;54(14):1209–27.
Krousel-Wood M, et al. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol. 2005;20(4):296–300.
Chang TE, et al. National rates of nonadherence to antihypertensive medications among insured adults with hypertension, 2015. Hypertension. 2019;74(6):1324–32.
Lee H, et al. Adherence to antihypertensive medication and incident cardiovascular events in young adults with hypertension. Hypertension. 2021;77(4):1341–9.
Tsioufis K, et al. Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature. J Hypertens. 2020;38(6):1016–28.
Flack JM, Nasser SA. Benefits of once-daily therapies in the treatment of hypertension. Vasc Health Risk Manag. 2011;7:777–87.
Umemura S, et al. The Japanese Society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235–481.
Park BE, et al. Comparison of the efficiency between electrocardiogram and echocardiogram for left ventricular hypertrophy evaluation in patients with hypertension: Insight from the Korean Hypertension Cohort Study. J Clin Hypertens (Greenwich). 2022;24(11):1451–60.
Fujiyoshi A, et al. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res. 2012;35(9):947–53.
Lewington S, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13.
Kassai B, et al. Treatment of high blood pressure and gain in event-free life expectancy. Vasc Health Risk Manag. 2005;1(2):163–9.